With micro-disc rheometry, we have been able to map out the viscosity of dipalmitoylphosphatidylcholine monolayers, and determine how the viscosity changes with additions of cholesterol and/or palmitic acid, which are common additives to clinical lung surfactants. We find that 1-3 wt% cholesterol (similar to that found in Infasurf, a clinical replacement surfactant) induces a two-three order of magnitude drop in the interfacial rheology. This drop correlates very well with the decrease in molecular coherence of the DPPC lattice as measure with synchrotron X-ray diffraction when used in a free-area model of the viscosity. However, palmitic acid induces a two order of magnitude increase in the viscosity of DPPC which is only partly correlated with the increase in molecular coherence of DPPC. Instead, a better explanation of the effects of PA on DPPC is the formation of a highly organized, low tilt phase that is about 1:1 DPPC:PA that appears at low surface pressure. For mixtures in which the PA fraction is below equimolar, we obtain a mixed solid phase of the 1:1 DPPC:PA cocrystal and a liquid phase of nearly pure DPPC. This phase separation is exacerbated by the presence of cholesterol, which segregates to the liquid phase. As the surface pressure increases, a second crystal forms of nearly pure DPPC. This is accompanied by a dramatic change in the rate of change of the surface viscosity vs surface pressure. This solid-solid phase coexistence is likely common in many complex biological monolayers.
Read full abstract